Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07735403Recruiting

Dozee Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings

Role: lead

NCT07223931Completed

Validating Dozee for Contactless Monitoring of Heart, Breathing, and Movemen

Role: lead

NCT06270953Completed

Non-invasive Monitoring: Impact on Patient Management and Outcomes

Role: lead

NCT05380102Completed

Pilot Evaluation of an Continuous Contactless Vitals Parameter Monitoring System Dozee VS

Role: lead

NCT05153460Terminated

Pilot Clinical Evaluation of Dozee VS, a Contactless Continuous Vital Parameters Monitoring System in Hospital Patients

Role: lead

All 5 trials loaded